Fibricor 0.1mg Injection 10ml
Key Information
Generic Name
Generic Name Ibutilide 0.1 mg
Manufacturer
Zuventus Healthcare Ltd
Country of Origin
India
Detailed Information
Introduction
INTRODUCTION ABOUT FIBRICOR 0.1MG INJECTIONFIBRICOR 0.1MG INJECTION contains Ibutilide, which belongs to the group of medicines called Antiarrhythmics. FIBRICOR 0.1MG INJECTION is used for converting the abnormal heart rhythm to a normal heart rhythm in conditions such as atrial flutter (due to rapid abnormal contraction of the ventricles (lower heart chambers) of the heart) or atrial fibrillation (due to irregular electric impulses of the heart). Atrial fibrillation and atrial flutter are conditions due to an uneven contraction of the parts in the heart, resulting in a fast and irregular heartbeat. Symptoms of the conditions may include palpitations, tiredness, shortness of breath, feeling faint or light-headed, and chest pain. Your doctor may advise you to take relevant tests and evaluate your condition for hypokalaemia (low potassium levels) and hypomagnesemia (low magnesium levels) and stabilise their levels to reduce the potential for proarrhythmic events that may occur after receiving FIBRICOR 0.1MG INJECTION. FIBRICOR 0.1MG INJECTION is not recommended for use in patients suffering from polymorphic ventricular tachycardia, such as torsade de pointes (the lower chambers of the heart work faster than the upper heart chambers), congenital long QT syndrome (a hereditary heart condition causing ventricular arrhythmia), sinus node disease, structural heart disease, and uncorrected electrolyte abnormalities. FIBRICOR 0.1MG INJECTION should be used with caution in patients with QT prolongation, a family history of QT prolongation, recent myocardial infarction, bradycardia (slow heart rate), congestive heart failure or low ejection fraction, and heart block. FIBRICOR 0.1MG INJECTION is not recommended for use and should be used with caution in pregnant women, only if recommended by your doctor, as it may cause harm to the unborn as its safety and risk are not known. [GBN] is not recommended for use in breastfeeding mothers or children less than 18 years of age, as its safety and risks have not been established. In elderly patients over the age of 65, FIBRICOR 0.1MG INJECTION should be used with caution. The most common
Uses
OF FIBRICOR 0.1MG INJECTION Manage arrhythmic conditions such as atrial fibrillation or atrial flutter
How It Works
FIBRICOR 0.1MG INJECTION works by regulating the heartbeat by blocking the abnormal electrical signals in the heart. Thus, managing abnormal heart rhythm effectively.
Directions for Use
FIBRICOR 0.1MG INJECTION will be given to you only by a doctor or a nurse as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and severity of the disease.
Side Effects
receiving FIBRICOR 0.1MG INJECTION may include headache, low blood pressure and bradycardia (slow heart rate). Contact your physician if any of the symptoms get worse. USES OF FIBRICOR 0.1MG INJECTION Manage arrhythmic conditions such as atrial fibrillation or atrial flutter HOW FIBRICOR 0.1MG INJECTION WORKSFIBRICOR 0.1MG INJECTION works by regulating the heartbeat by blocking the abnormal electrical signals in the heart. Thus, managing abnormal heart rhythm effectively. DIRECTIONS FOR USEFIBRICOR 0.1MG INJECTION will be given to you only by a doctor or a nurse as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and severity of the disease. SIDE EFFECTS OF FIBRICOR 0.1MG INJECTIONCOMMON headache hypotension (low blood pressure) bradycardia (slow heart rate)
Warnings & Precautions
& PRECAUTIONSPREGNANCYFIBRICOR 0.1MG INJECTION should be used with caution in pregnant women, only if recommended by your doctor as its safety and risk are not known. Consult your doctor before receiving it. BREASTFEEDINGFIBRICOR 0.1MG INJECTION is not recommended for use in breastfeeding women as it is not known whether it could pass through breast milk. Consult your doctor before receiving it. KIDNEYThe safety and effectiveness of FIBRICOR 0.1MG INJECTION in patients with kidney disease have not been established. Consult your doctor before receiving it. LIVERThe safety and effectiveness of FIBRICOR 0.1MG INJECTION in patients with liver disease have not been established. Consult your doctor before receiving it. ALLERGYDo not receive FIBRICOR 0.1MG INJECTION if you are allergic to ibutilide, tolbutilide fumarate, or any of the other ingredients of this medicine. HEART DISEASEFIBRICOR 0.1MG INJECTION is not recommended for use in patients suffering from polymorphic ventricular tachycardia such as torsade’s de pointes pointes (the lower chambers of the heart work faster than the upper heart chambers), congenital long QT syndrome (hereditary heart condition causing ventricular arrhythmia), sinus node disease and structural heart disease. Consult your doctor before receiving it. FIBRICOR 0.1MG INJECTION should be used with caution in patients with QT prolongation, a family history of QT prolongation, recent myocardial infarction, bradycardia (slow heart rate), Congestive heart failure or low ejection fraction and heart block. Consult your doctor before receiving it. OTHERSFIBRICOR 0.1MG INJECTION is not recommended for use if you have: uncorrected electrolyte abnormalities Use in paediatrics: FIBRICOR 0.1MG INJECTION is not recommended for use in children below 18 years of age as its safety and risks in children are not yet established. Consult your doctor before receiving it. Use in geriatrics: FIBRICOR 0.1MG INJECTION should be used with caution in elderly patients 65 years of age. Consult your doctor before it.
Drug Interactions
SA. Drug-Drug interactions: Before receiving FIBRICOR 0.1MG INJECTION, inform your doctor if you are taking any of the following medicine: amifampridine (used to manage muscle diseases) fingolimod (used to manage multiple sclerosis) hydroxychloroquine, halofantrine (used to manage malaria) macimorelin (a medicine used for diagnoses of adult growth hormone deficiency) mifepristone (used to manage medical abortion) mizolastine, bilastine, terfenadine, astemizole (a medicine used to manage allergic conditions such as urticaria and rhinoconjunctivitis) probucol (a medicine used to decrease cholesterol levels) promazine, ziprasidone, thioridazine (used to manage schizophrenia) vinflunine (used to manage cancer) indapamide, xipamide (medicines used for the management of high blood pressure) fluoxetine, amitriptyline, amoxapine (medicines used for the management of depression, panic disorder, etc.) pefloxacin, Erythromycin IV (medicines used to manage bacterial infections) teneligliptin (used to manage diabetes) cisapride (a medicine used for heartburn) levoketoconazole (used to manage Cushing’s syndrome) pimozide (a medicine used to control motor and verbal ticks) disopyramide, quinidine, procainamide, amiodarone, sotalol, and dronedarone (medicines used to manage abnormal heart rhythm) digoxin (used to manage heart failure) Overdosage: FIBRICOR 0.1MG INJECTION will be administered to you only by a doctor or a nurse in the hospital, so it is unlikely for you to receive an overdose. However, contact your physician immediately if you experience any unusual side effects. Symptoms of overdosage may include increased ventricular ectopy (extra abnormal heartbeats) and monomorphic ventricular tachycardia, AV block- 3rd degree and non-sustained polymorphic ventricular tachycardia. SYNOPSIS Drug : Ibutilide Pharmacological Category : Antiarrhythmics Therapeutic Indication : Rapid conversion of atrial flutter or atrial fibrillation into normal sinus rhythm Dosage Forms : Injection MORE INFORMATION Keep FIBRICOR 0.1MG INJECTION out of reach from children Store at room temperature below 25°C
Article Information
Written By
DETAILS Written By Dr. Dhivakaran R
Medical Content Writer
Reviewed By
Dr. Sankara Babu Gorle
Medical Expert
Last Updated
06 Dec 2022